---

$0.17

-0.0098 ( -5.51% ) 7.1M

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-08-20	Buy	26050.00	Milligan Sandra
2025-08-20	Buy	26050.00	Milligan Sandra
2024-06-25	Sale	-1908.00	Aranda Richard
2024-06-24	Buy	372000.00	Hasnain Faheem
2024-06-20	Buy	100000.00	Giraudo Bryan
2024-06-20	Buy	25000.00	Smith Robert Paul JR
2024-06-06	Sale	-115000.00	Milligan Sandra
2024-06-06	Sale	-115000.00	Quisel John D
2024-06-06	Sale	-115000.00	Daniel Thomas O
2024-06-06	Sale	-115000.00	Cox Russell J.